Eleonora Orloff

Dr. Eleonora Orloff is a physician, healthcare operator, and investor with a focus on advancing clinical service operations and innovative care delivery models. She is the founding partner of a large, multi-specialty eye care practice in New York, where she leads both clinical and operational strategy, integrating cutting-edge diagnostics, AI-driven solutions, and patient-centered care.

 

Dr. Orloff currently serves as a Principal Clinical Investigator on a post-approval safety study with CooperVision and is Co-Founder of TearDx, a biotechnology venture exploring the diagnostic potential of tear fluid. Her work sits at the intersection of clinical medicine, research, and scalable healthcare innovation.

 

She earned her Executive MBA from Harvard Business School and is currently a candidate for a Master of Science in Clinical Service Operations at Harvard Medical School, where she is further developing expertise in healthcare systems, operational excellence, and industry innovation.

 

In addition to her clinical and entrepreneurial work, Dr. Orloff is actively engaged in healthcare investing and advisory roles, contributing to the evaluation and growth of early-stage companies. She currently serves as Co-Chair of the Membership Committee for HBSAANY.

 

Dr. Orloff feels deeply privileged to be part of the Harvard Business School Alumni Angels community—an exceptional group of innovative, forward-thinking leaders. She values the collaborative spirit and shared commitment to impact that define this network.

 

Her mission is to meaningfully improve healthcare delivery by bridging clinical expertise with operational strategy, technology, and innovation—ultimately driving better outcomes and creating lasting value for patients and society.